Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis.

Arthritis Res Ther · 2015 · PMC4535682 · PMID 26268352

Europe PMC DOI

hedged sentence

0.1050

closest p · 2.1× alpha

0.1050

boldest claim

The sentences

did not reach statistical significanceP = 0.105not close (p > 0.1)

RRs were also less frequently AMCV IgM-positive at baseline compared to NRRs (43 % versus 69 %), but this difference did not reach statistical significance (χ 2 P = 0.105).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.